Molecular characterization of the in vivo alkylating agent resistant murine EMT-6 mammary carcinoma tumors. (Q54185365)

26 May 2018

title

Molecular characterization of the in vivo alkylating agent resistant murine EMT-6 mammary carcinoma tumors. (English)

1 reference

26 May 2018

author name string

D Chatterjee

1

1 reference

26 May 2018

C J Liu

2

1 reference

26 May 2018

D Northey

3

1 reference

26 May 2018

B A Teicher

4

1 reference

26 May 2018

publication date

1 January 1995

1 reference

26 May 2018

Cancer Chemotherapy and Pharmacology

published in

1 reference

26 May 2018

volume

35

1 reference

26 May 2018

issue

5

1 reference

26 May 2018

page(s)

423-431

1 reference

26 May 2018

https://scigraph.springernature.com/pub.10.1007/s002800050257

exact match

0 references

cites work

Expression and purification of the leucine zipper and DNA-binding domains of Fos and Jun: both Fos and Jun contact DNA directly

1 reference

https://api.crossref.org/works/10.1007%2FS002800050257

Coupled and uncoupled induction of fos and jun transcription by different second messengers in cells of hematopoietic origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050257

Temporally defined induction of c-fos in the rat pineal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050257

The c-Fos protein interacts with c-Jun/AP-1 to stimulate transcription of AP-1 responsive genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050257

Immune response to p53 is dependent upon p53/HSP70 complexes in breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050257

EGF receptor and erbB-2 tyrosine kinase domains confer cell specificity for mitogenic signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050257

Two oncogenes, v-fos and v-ras, cooperate to convert normal keratinocytes to squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050257

p53 alteration is a common event in the spontaneous immortalization of primary BALB/c murine embryo fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050257

'Nuclear' oncogenes convert extracellular stimuli into changes in the genetic program

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050257

p53 mutations in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050257

Coamplification of the L-myc and N-myc oncogenes in a neuroblastoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050257

Effect of antisense c-raf-1 on tumorigenicity and radiation sensitivity of a human squamous carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050257

Autoinduction of transforming growth factor beta 1 is mediated by the AP-1 complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050257

Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050257

Activation of ras oncogenes preceding the onset of neoplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050257

p53 mutations increase resistance to ionizing radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050257

p53-dependent apoptosis modulates the cytotoxicity of anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050257

Characterization of c-Ki-ras and N-ras oncogenes in aflatoxin B1-induced rat liver tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050257

Molecular switch for signal transduction: structural differences between active and inactive forms of protooncogenic ras proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050257

Increased phosphorylation of nuclear phosphoproteins in human lung‐cancer cells resistant to cis‐diamminedichloroplatinum(II)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050257

Epidermal growth factor stimulates transcription of the c-jun proto-oncogene in rat fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050257

Neoplastic transformation and tumorigenesis by the human protooncogene MYC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050257

Nuclear proto-oncogenes fos and jun.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050257

Fos-associated protein p39 is the product of the jun proto-oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050257

Microinjection of fos-specific antibodies blocks DNA synthesis in fibroblast cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050257

Induction of protooncogene c-jun by serum growth factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050257

Tumor suppressor genes: the puzzle and the promise

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050257

fos-associated cellular p39 is related to nuclear transcription factor AP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050257

Elevated expression of thymidylate synthase cycle genes in cisplatin-resistant human ovarian carcinoma A2780 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050257

Repression of c-fos transcription and an altered genetic program in senescent human fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050257

Ionizing radiation regulates expression of the c-jun protooncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050257

Loss of the MYC gene amplified in human HL-60 cells after treatment with inhibitors of poly(ADP-ribose) polymerase or with dimethyl sulfoxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050257

Tumor resistance to alkylating agents conferred by mechanisms operative only in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050257

Protection of bone-marrow granulocyte-macrophage colony-forming units in mice bearing in vivo alkylating-agent-resistant EMT-6 tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050257

Prognostic significance of "short-term" effects of chemotherapy on MYC and histone H3 mRNA levels in acute leukemia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050257

The oncogene jun and nuclear signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050257

Association of human papillomavirus types 16 and 18 E6 proteins with p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050257

Heparin suppresses the induction of c-fos and c-myc mRNA in murine fibroblasts by selective inhibition of a protein kinase C-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050257

The N-myc gene product in primary retinoblastomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050257

Redox regulation of fos and jun DNA-binding activity in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050257

Presence of two members of c-erbA receptor gene family (c-erbA beta and c-erbA2) in smallest region of somatic homozygosity on chromosome 3p21-p25 in human breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050257

An immunohistochemical analysis of ras oncogene expression in epithelial neoplasms of the colon

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800050257

Reversible suppression of c-myc expression in a human colon carcinoma line by the anticancer agent N-methylformamide

21 January 2018

1 reference

12 December 2020

Embryonic stem (ES) cells lacking functional c-jun: consequences for growth and differentiation, AP-1 activity and tumorigenicity

1 reference

12 December 2020

p53 mutations in breast cancer

1 reference

12 December 2020

Molecular basis of cisplatin resistance in human carcinomas: model systems and patients.

1 reference

12 December 2020

Amplification of c-myc but not of c-erbB-2 is associated with high proliferative capacity in breast cancer

1 reference

12 December 2020

Elevation of c-myc protein by DNA strand breakage

1 reference

12 December 2020

Function of Ras as a molecular switch in signal transduction

1 reference

12 December 2020

Fos and jun: two into one will go.

1 reference

12 December 2020

Amplification of N-myc and ornithine decarboxylase genes in human neuroblastoma and hydroxyurea-resistant hamster cell lines

1 reference

12 December 2020

Identification of a membrane glycoprotein overexpressed in murine lymphoma sublines resistant to cis-diamminedichloroplatinum(II).

1 reference

12 December 2020

Activated ras genes in human seminoma: evidence for tumor heterogeneity.

1 reference

12 December 2020

Changes in c-myc and c-fos expression in a human tumor cell line following exposure to bifunctional alkylating agents.

1 reference

12 December 2020

Differences between normal and ras-transformed NIH-3T3 cells in expression of the 170kD and 180kD forms of topoisomerase II.

1 reference

12 December 2020

Elevated expression of the c-myc oncoprotein correlates with poor prognosis in head and neck squamous cell carcinoma

1 reference

12 December 2020

Synergistic effect of the v-myc oncogene with H-ras on radioresistance.

1 reference

12 December 2020

Expression of transfected recombinant oncogenes increases radiation resistance of clonal hematopoietic and fibroblast cell lines selectively at clinical low dose rate

1 reference

12 December 2020

c-myc and c-fos gene regulation during mouse liver regeneration.

1 reference

12 December 2020

Transcriptional and post-transcriptional regulation of c-jun expression during monocytic differentiation of human myeloid leukemic cells

1 reference

12 December 2020

Altered expression of wild-type p53 tumor suppressor gene during murine epithelial cell transformation

1 reference

12 December 2020

Inherited p53 gene mutations in breast cancer

1 reference

12 December 2020

Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis

1 reference

12 December 2020

c-Ha-ras oncogene expression in immortalized human keratinocytes (HaCaT) alters growth potential in vivo but lacks correlation with malignancy

1 reference

12 December 2020

Expression of the c-Ha-ras oncogene in mouse NIH 3T3 cells induces resistance to cisplatin

1 reference

12 December 2020

The role of the H-ras oncogene in radiation resistance and metastasis

1 reference

12 December 2020

The neu (c-erbB-2) oncogene

1 reference

12 December 2020

ras oncogenes in human cancer: a review

1 reference

12 December 2020

Induction of fos RNA by DNA-damaging agents

1 reference

12 December 2020

Development of alkylating agent-resistant human tumor cell lines

1 reference

12 December 2020

Analysis of the int-1, int-2, c-myc, and neu oncogenes in human breast carcinomas

1 reference

12 December 2020

Increased erbB-2 gene copies and expression in multiple stages of breast cancer

1 reference

12 December 2020

The effect of cisplatin and carboplatin on c-myc promoter in erythroleukemic cells

1 reference

12 December 2020

c-fos expression induces bone tumors in transgenic mice

1 reference

12 December 2020

Alkylating agents: in vitro studies of cross-resistance patterns in human cell lines.

1 reference

12 December 2020

Increased resistance to cis-diamminedichloroplatinum(II) in NIH 3T3 cells transformed by ras oncogenes

1 reference

12 December 2020

Overexpression of DNA replication and repair enzymes in cisplatin-resistant human colon carcinoma HCT8 cells and circumvention by azidothymidine

1 reference

12 December 2020

K-ras activation in neoplasms of the human female reproductive tract

1 reference

12 December 2020

Alkalinization of the lysosomes is correlated with ras transformation of murine and human fibroblasts

1 reference

12 December 2020

Amplification of the c-myc oncogene during progression of radiation-induced rat skin tumors

1 reference

12 December 2020

Inverse correlation between expression of multidrug resistance gene and N-myc oncogene in human neuroblastomas.

1 reference

12 December 2020

Differential expression of the c-erbB-2 gene in human small cell and non-small cell lung cancer

1 reference

12 December 2020

ras gene activation in rat tumors induced by benzidine congeners and derived dyes

1 reference

12 December 2020

c-Ha-ras-I oncogene-induced differentiation and natural killer cell resistance in a human colorectal carcinoma cell line.

1 reference

12 December 2020

Relationship between the formation of promutagenic adducts and the activation of the K-ras protooncogene in lung tumors from A/J mice treated with nitrosamines

1 reference

12 December 2020

Identifiers

DOI

10.1007/S002800050257

1 reference

26 May 2018

1 reference

26 May 2018